Malaysia approves use of Sinovac COVID-19 vaccine as booster shot
0 Comment(s)
Print
E-mail Xinhua, November 17, 2021
KUALA LUMPUR, Nov. 17 (Xinhua) -- Malaysian regulators on Wednesday announced the conditional approval for use of the CoronaVac COVID-19 vaccine developed by the Chinese pharmaceutical company Sinovac Biotech as booster shots for those aged 18 and above.
Health Ministry Director-General Noor Hisham Abdullah said in a statement that the Sinovac booster shot will be administered for targeted groups from three to six months after receiving the first two shots.
He added that the approval requires that the information about the quality, safety and effectiveness of the vaccine must be monitored and evaluated regularly based on the latest data available.
Both the finished products of Sinovac vaccines imported from China and those manufactured by Malaysian pharmaceutical company Pharmaniaga have been used in the country's national immunization program after receiving approval.
Malaysia administered 121,232 vaccine doses on Tuesday alone. Some 78.5 percent of the population have received at least one dose and 76.2 percent are fully vaccinated. Enditem
Go to Forum >>0 Comment(s)